Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

May 2018; 5 (3) Clinical/Scientific NotesOpen Access

Effective treatment of CLIPPERS with long-term use of rituximab

Veronica P. Cipriani, Nancy Arndt, Peter Pytel, Anthony T. Reder, Adil Javed
First published March 1, 2018, DOI: https://doi.org/10.1212/NXI.0000000000000448
Veronica P. Cipriani
From the Department of Neurology (V.P.C., N.A., A.T.R., A.J.), and Department of Pathology (P.P.), University of Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Arndt
From the Department of Neurology (V.P.C., N.A., A.T.R., A.J.), and Department of Pathology (P.P.), University of Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Pytel
From the Department of Neurology (V.P.C., N.A., A.T.R., A.J.), and Department of Pathology (P.P.), University of Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony T. Reder
From the Department of Neurology (V.P.C., N.A., A.T.R., A.J.), and Department of Pathology (P.P.), University of Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adil Javed
From the Department of Neurology (V.P.C., N.A., A.T.R., A.J.), and Department of Pathology (P.P.), University of Chicago, IL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Effective treatment of CLIPPERS with long-term use of rituximab
Veronica P. Cipriani, Nancy Arndt, Peter Pytel, Anthony T. Reder, Adil Javed
Neurol Neuroimmunol Neuroinflamm May 2018, 5 (3) e448; DOI: 10.1212/NXI.0000000000000448

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
2863

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 5 no. 3 e448
DOI: 
https://doi.org/10.1212/NXI.0000000000000448

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received December 6, 2017
  • Accepted in final form January 17, 2018
  • First Published March 1, 2018.

Copyright & Usage: 
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Veronica P. Cipriani, MD,
    2. Nancy Arndt, RN, MSCN,
    3. Peter Pytel, MD,
    4. Anthony T. Reder, MD and
    5. Adil Javed, MD, PhD
  1. Veronica P. Cipriani, MD,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. National MS Society

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Nancy Arndt, RN, MSCN,
  4. Scientific Advisory Boards:
    1. 1.)Genzyme 3.)Bayer

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. 1.)Genzyme 2.)Teva

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. 1.)Genzyme 2.)Teva

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Peter Pytel, MD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Editorial board of Modern Pathology

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NIA funding as co-investigator for unrelated studies on myopathies.

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. Acted as expert witness for an law firm

  7. Anthony T. Reder, MD and
  8. Scientific Advisory Boards:
    1. (1) Abbott, ImmunoScience, Inc., (2) Questcor/Malinkrodt, (3) AstraZeneca, (4)Merck Serono, (5) Athena Diagnostics, Inc., (6) Sanofi-Aventis, (7) Bayer, (8) Biogen Idec, (9) BioMS Medical, (10) Blue Cross Blue Shield, (11) Boehringer Ingelheim, (12) Caremark Rx, (13) Centocor Ortho Biotech Inc., (14) Cephalon, Inc., (15) Connetics Corp., (16) CroMedica Global Inc., (17) Eli Lilly and Company, (18) Elan Corporation, (19) Genentech, Inc., (20) Genzyme Corporation, (21) GlaxoSmithKline, (22) Hoechst Marion Roussel Canada Research, Inc., (23) Roche, (24) Immunex Corporation, (25) Institute for Health Care Quality, (26) Johnson & Johnson, (27) Yale University, (28) Barrow Neurological Institute, (29) National Multiple Sclerosis Society & Paralyzed Veterans of America, (30) Neurocrine Biosciences, (31) Novartis, (32) Parke-Davis, (33) Pfizer Inc., (34) Pharmacia & Upjohn, (35) Protein Design Labs, Inc., (36) Quantum Biotechnologies, Inc., (37) Quintiles, Inc., (38) EMD Serono, Inc., (39 Sention, Inc., (40) Smith Kline- Beecham, (41) Specialized Therapeutics (a division of Berlipharm, Inc.), (42) Takeda Pharmaceutical Company Limited, (43) Teva Pharmaceutical Industries Ltd.

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. (1) Abbott, ImmunoScience, Inc., (2) Questcor/Malinkrodt, (3) AstraZeneca, (4)Merck Serono, (5) Athena Diagnostics, Inc., (6) Sanofi-Aventis, (7) Bayer Schering Pharma, (8) Biogen Idec, (9) BioMS Medical, (10) Blue Cross Blue Shield, (11) Boehringer Ingelheim, (12) Caremark Rx, (13) Centocor Ortho Biotech Inc., (14) Cephalon, Inc., (15) Connetics Corp., (16) CroMedica Global Inc., (17) Eli Lilly and Company, (18) Elan Corporation, (19) Genentech, Inc., (20) Genzyme Corporation, (21) GlaxoSmithKline, (22) Hoechst Marion Roussel Canada Research, Inc., (23) Roche, (24) Immunex Corporation, (25) Institute for Health Care Quality, (26) Johnson & Johnson, (27) Yale University, (28) Barrow Neurological Institute, (29) National Multiple Sclerosis Society & Paralyzed Veterans of America, (30) Neurocrine Biosciences, (31) Novartis, (32) Parke-Davis, (33) Pfizer Inc., (34) Pharmacia & Upjohn, (35) Protein Design Labs, Inc., (36) Quantum Biotechnologies, Inc., (37) Quintiles, Inc., (38) EMD Serono, Inc., (39 Sention, Inc., (40) Smith Kline- Beecham, (41) Specialized Therapeutics (a division of Berlipharm, Inc.), (42) Takeda Pharmaceutical Company Limited, (43) Teva Pharmaceutical Industries Ltd.

    Editorial Boards:
    1. (1) Medlink/Neurobase Editorial Board, Arbor Publishing Corporation, San Diego, CA, 1999-Present; (2) Turkish Journal of Medical Sciences, Editorial Board, 2001- present; (3) T?rk N?roloji Dergisi (Turkish Journal of Neurology), Editorial Board, 2004-present

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. (1) Abbott, (2) Questcor/Malinkrodt,(3) AstraZeneca, (4) Merck Serono, (5) Athena Diagnostics, Inc., (6) Sanofi- Aventis, (7) Bayer Schering Pharma, (8) Biogen Idec, (9) BioMS Medical, (10) Blue Cross Blue Shield, (11) Boehringer Ingelheim, (12) Caremark Rx, (13) Centocor Ortho Biotech Inc., (14) Cephalon, Inc., (15) Connetics Corp., (16) CroMedica Global Inc., (17) Eli Lilly and Company, (18) Elan Corporation, (19) Genentech, Inc., (20) Genzyme Corporation, (21) GlaxoSmithKline, (22) Hoechst Marion Roussel Canada Research, Inc., (23) Roche, (24) Immunex Corporation, (25) Institute for Health Care Quality, (26) Johnson & Johnson, (27) Yale University, (28) Barrow Neurological Institute, (29) National Multiple Sclerosis Society & Paralyzed Veterans of America, (30) Neurocrine Biosciences, (31) Novartis, (32) Parke-Davis, (33) Pfizer Inc., (34) Pharmacia & Upjohn, (35) Protein Design Labs, Inc., (36) Quantum Biotechnologies, Inc., (37) Quintiles, Inc., (38) EMD Serono, Inc., (39 Sention, Inc., (40) Smith Kline- Beecham, (41) Specialized Therapeutics (a division of Berlipharm, Inc.), (42) Takeda Pharmaceutical Company Limited, (43) Teva Pharmaceutical Industries Ltd.

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Novartis, (2) Bayer, (3) Serono, Inc., (4) Chugai, (5) Genzyme,(6) Biogen Idec, (7)Medimmune (8) Genentech/Roche, Inc., (8) Medday

    Research Support, Government Entities:
    1. (1) NIH/NINDS RO1 NS 051591, Site PI; (2) NIH 1 K24 RR021948, PI. (2) Chinese Government, (3) Turkish Ministry of Defense Fellowship Award, (4) the State of Illinois

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. (1) the National MS Society, (2) the Brain Research Foundation, (3) the American Academy of Allergy & Immunology, (4) Howard Hughes Foundation, (5) Egypt Arab Republic Peace Fellowship,

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Adil Javed, MD, PhD
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. Dr. Javed has been a consultant for Biogen, Sanofi- Genzyme, Serono, Mallinckrodt, and Genentech.

    Speakers' Bureaus:
    1. Dr. Javed serves on the speaker's bureau for Biogen, Sanofi-Genzyme, Serono, Teva, Mallinckrodt, and Genentech.

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From the Department of Neurology (V.P.C., N.A., A.T.R., A.J.), and Department of Pathology (P.P.), University of Chicago, IL.
  1. Correspondence
    Dr. Cipriani vpenyak{at}gmail.com
View Full Text

Article usage

Article usage: March 2018 to December 2022

AbstractFullPdfSource
Mar 2018031493Highwire
Apr 201804329Highwire
Apr 2018204752pmc
May 2018031086Highwire
Jun 2018089074Highwire
Jun 201893441pmc
Jul 2018018599Highwire
Aug 2018196144Highwire
Aug 201852628pmc
Sep 2018073125Highwire
Oct 20180104126Highwire
Nov 201809796Highwire
Dec 20180114114Highwire
Jan 2019165112Highwire
Feb 2019645101Highwire
Mar 2019362111Highwire
Apr 201925174Highwire
May 201984069Highwire
Jun 201933168Highwire
Jul 2019682105Highwire
Aug 2019239135Highwire
Sep 201923759Highwire
Oct 201925079Highwire
Nov 201965353Highwire
Dec 201933933Highwire
Jan 202025542Highwire
Feb 202003844Highwire
Mar 202022743Highwire
Apr 202013617Highwire
May 202023420Highwire
Jun 202008038Highwire
Jul 202035328Highwire
Aug 202006325Highwire
Sep 202036317Highwire
Oct 202014132Highwire
Nov 202045426Highwire
Dec 202017416Highwire
Jan 202125414Highwire
Feb 202116312Highwire
Mar 202157115Highwire
Apr 202134715Highwire
May 20213835Highwire
Jun 202129414Highwire
Jul 202135518Highwire
Aug 202107715Highwire
Sep 202155518Highwire
Oct 202105932Highwire
Nov 202165621Highwire
Dec 202115518Highwire
Jan 202256729Highwire
Feb 202225913Highwire
Mar 202227420Highwire
Apr 202214117Highwire
May 202207232Highwire
Jun 202225616Highwire
Jul 20223454Highwire
Aug 202214710Highwire
Sep 202207515Highwire
Oct 202225724Highwire
Nov 202219334Highwire
Dec 20222518Highwire

Cited By...

  • 13 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Classification of evidence
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Preferences and User Experiences of Wearable Devices in Epilepsy A Systematic Review and Mixed-Methods Synthesis

Dr. Daniel Friedman and Dr. Sharon Chiang

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Clinical Neurology
  • All Demyelinating disease (CNS)
  • MRI

Alert Me

  • Alert me when eletters are published
Neurology - Neuroimmunology Neuroinflammation: 10 (2)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise